Transcatheter Valve Replacement Market
Transcatheter Valve Replacement Market Analysis, By Replacement Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Repair (TMVR)), By Surgical Approach (Trans-femoral, Trans-apical, Trans-aortic Approach), by End User, by Region - Global Forecast 2022 to 2032
Analysis of Transcatheter Valve Replacement market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Transcatheter Valve Replacement Market Outlook (2022 to 2032)
The global transcatheter valve replacement market is valued at US$ 3.6 billion. The market is projected to expand at an impressive CAGR of 13.4% and generate an absolute dollar opportunity worth US$ 9.2 billion over the assessment period (2022 to 2032).
| Report Attributes | Details |
|---|---|
| Transcatheter Valve Replacement Market Size (2021A) | US$ 3.2 Billion |
| Estimated Market Value (2022E) | US$ 3.6 Billion |
| Forecasted Market Value (2032F) | US$ 12.8 Billion |
| Global Market Growth Rate (2022 to 2032) | 13.4% CAGR |
| North America Market Share (2021) | ~27% |
| North America Growth Rate (2022 to 2032) | ~13.5% CAGR |
| United States Growth Rate (2022 to 2032) | ~13.7% CAGR |
| Market Share of Top 5 Companies | ~45% |
| Key Companies Profiled | Edwards Lifesciences Corporation; Medtronic Inc.; Boston Scientific Corporation; Abbott Laboratories; St. Jude Medical, Inc.; JenaValve Technology; SYMETIS; Braile Biomedica; CryoLife, Inc.; Micro Interventional Devices, Inc.; LivaNova Plc |
Rising prevalence of aortic valve defects among patients and their demand to undergo minimally invasive surgeries with fewer complications as compared to surgical aortic valve replacement or open-heart surgeries are factors driving market expansion.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Transcatheter Valve Replacement Market Analysis (2017 to 2021) Vs. Growth Forecasts (2022 to 2032)
Valve diseases and valve regurgitation have been emerging as leading causes of death over the last few years. Bicuspid aortic valve faults occur in more than 13 out of 1,000 people in the United States, according to the American Heart Association. Rising prevalence of cardiac valve disorders is supporting the growth of the transcatheter heart valve replacement market.
These replacement procedures are minimally-invasive procedures for replacing thickened aortic valves. These surgeries help in restoring blood flow and aid in reducing the signs and symptoms of aortic valve stenosis.
Patients at risk from open-heart surgery because of complications can prefer transcatheter valve replacement owing to its various benefits.
- Short Term (2022 Q2 to 2025): Rise in patients with heart diseases fueling transcatheter valve replacement market growth.
- Medium Term (2025 to 2028): Market likely to uplift in Asia Pacific region on the back of rapid adoption of transcatheter valves, rising geriatric population, improving health infrastructure, and strong government support.
- Long Term (2028 to 2032): Transcatheter valve replacement market bound to grow on the back of improvements in surgeries along with the launch of innovative products.
The global transcatheter valve replacement market witnessed 10% CAGR from 2017 to 2021. According to the recent analysis done by Fact.MR, a market research and competitive intelligence provider, the global market is projected to expand 13.4% CAGR during the forecast years (2022 to 2032).
Market share analysis of replacement type and region are provided in a nutshell. Under the replacement type segment, transcatheter aortic valve replacement (TAVR) held a dominant position in the market with 78.6% share in 2021.
Why is Demand for Transcatheter Valve Replacement Expected to Surge?
“High Demand for Less Invasive Surgeries to Fuel Market Growth”
Transcatheter valve replacement is a minimally-invasive procedure where a new valve is implanted without removing the old or damaged valve. The surgery is similar to placing a stent in the artery and is available for people with symptomatic aortic stenosis who are at low, intermediate, or high risk of standard valve replacement surgery.
In addition, the major advantage of the transcatheter valve replacement procedure is that it can be done through small openings, thereby leaving all chest bones in place. It is also a beneficial treatment option for patients who have not been considered for a valve replacement procedure.
These surgeries require patients to spend less time in hospitals as compared to surgical valve replacement. Also, the procedure is beneficial to patients in all risk categories and offers an effective option to improve the quality of life for those who may otherwise have limited options for aortic valve repair.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Factors May Impede Transcatheter Valve Replacement Market Growth?
Aftermath Risks of Surgeries to Hamper Market Growth
All types of surgical procedures come with some type of risk. Transcatheter valve replacement procedures also include potential risks, which may hamper market growth to some extent.
For instance, these surgeries may lead to bleeding, kidney disease, heart attack, infection, and stroke. Other possible risks include blood vessel complications, problems with replacement valves such as leaking or valve slipping, arrhythmias, and sometimes even death.
Country-wise Insights
Why is the U.S. a Lucrative Market for Transcatheter Valve Replacement?
The United States transcatheter valve replacement market holds approximately 88.2% share in the North America transcatheter valve replacement market. The U.S. market is poised to expand at the rate of 13.6% owing to the rising prevalence of heart valve diseases and disorders in the country.
More than 5 million people are diagnosed with heart valve disease annually and more than 80,000 aortic valve replacement procedures are carried out in the country every year.
Along with this, favorable reimbursement scenarios for these procedures are additionally fueling the number of patients undergoing this treatment. Also, rising number of transcatheter valve replacement centres in the United States is likely to uplift market growth in the country over the coming years.
Why Does Germany Dominate the European Transcatheter Valve Replacement Market?
The Germany transcatheter valve replacement market dominates the European transcatheter valve replacement market with 23.4% share. The market in Germany is likely to surge owing to improved healthcare infrastructure and increasing prevalence of aortic stenosis in the geriatric population in the country.
More than 25,000 replacement procedures are carried out in Germany every year, according to statistics. Germany is also leading in the clinical adoption of TAVR and TAVI implantations.
Furthermore, the presence of highly skilled interdisciplinary heart specialists in the country is contributing to market growth in Germany, and, in turn, growth of the European market.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Will Demand for Transcatheter Aortic Valve Replacement Remain High Going Forward?
Under replacement type, the transcatheter valve replacement market is segmented into transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR).
The transcatheter aortic valve replacement segment holds a dominant position in the market with 78.6% share. The segment is projected to rise at the rate of 13.6% on the back of TAVR being applied to patients at all risk levels and patients with the disease being treated without having to undergo open-heart surgery.
Also, TAVR requires patients undergoing minimally-invasive procedures to be administered minimal or no anesthesia, allowing them to be discharged from the hospital the next day. These factors are likely to support segmental growth during the forecast years.
On the other hand, transcatheter mitral valve repair (TMVR) holds 21.4% share in the overall market and is projected to rise at 13.2% CAGR through 2032.
Which Surgical Approach Accounts for a Large Share in Transcatheter Valve Replacement?
Under surgical approach, the transcatheter valve replacement market is segmented into trans-femoral approach, trans-apical approach, and trans-aortic approach.
Amongst them, the trans-femoral approach holds 78.9% market share. The segment is projected to rise at 13.8% CAGR owing to factors such as augmented focus on investigational products.
Why are Hospitals the Main Centres for Transcatheter Valve Replacement Procedures?
Under end user, the transcatheter valve replacement market is segmented into hospitals, ambulatory surgical centres, specialty clinics, and others.
Amongst them, hospitals dominate the market with 65.4% share and are poised to rise at the rate of 14.2% during the forecast years. This high growth is attributed to patients seeking efficient and effective treatment reducing recovery time and hospital stay. Also, high adoption of new medical devices and technologies in hospitals will support segmental growth over the decade.
Competitive Landscape
Prominent market players are concentrating on innovation and collaborations with other market players to meet the varied needs of patients. The market is being driven by greater awareness, advances in technologies, and geographic expansions.
- Edwards Lifesciences Corporation announced a strategic investment to acquire Corvia Medical, Inc., in 2019. The company designs devices to treat heart failure with preserved or mid-range ejection fraction and devices that provide dynamic and continuous decompression of the left atrium, reducing symptoms and slowing the progression of heart failure.
- Medtronic Inc. announced the acquisition of Affera, a cardiac arrhythmia treatment developer, in 2022. This acquisition is likely to expand the cardiac ablation portfolio of the company, enabling the creation of maps to diagnose arrhythmias.
Fact.MR has provided detailed information about the price points of key players in the transcatheter valve replacement market positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Segments Covered in Transcatheter Valve Replacement Industry Research
-
By Replacement Type :
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcatheter Mitral Valve Repair (TMVR)
-
By Surgical Approach :
- Trans-femoral Approach
- Trans-apical Approach
- Trans-aortic Approach
-
By End User :
- Hospitals
- Ambulatory Surgical Centres
- Specialty Clinics
- Others
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background and Foundation Data Points
- 4. Value Chain Analysis
- 5. Global Market - Pricing Analysis
- 6. Global Market Value 2017 to 2021 Analysis and Forecast, 2022 to 2032
- 7. Global Market 2017 to 2021 Analysis and Forecast 2022 to 2032, By Replacement Type
- 7.1. Transcatheter Aortic Valve Replacement (TAVR)
- 7.2. Transcatheter Mitral Valve Repair (TMVR)
- 8. Global Market 2017 to 2021 Analysis and Forecast 2022 to 2032, By Surgical Approach
- 8.1. Trans-femoral Approach
- 8.2. Trans-apical Approach
- 8.3. Trans-aortic Approach
- 9. Global Market 2017 to 2021 Analysis and Forecast 2022 to 2032, By End-User
- 9.1. Hospitals
- 9.2. Ambulatory Surgical Centres
- 9.3. Specialty Clinics
- 9.4. Others
- 10. Global Market 2017 to 2021 Analysis and Forecast 2022 to 2032, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Europe
- 10.4. East Asia
- 10.5. South Asia & Oceania
- 10.6. Middle East and Africa (MEA)
- 11. North America Market 2017 to 2021 Analysis and Forecast 2022 to 2032
- 12. Latin America Market 2017 to 2021 Analysis and Forecast 2022 to 2032
- 13. Europe Market 2017 to 2021 Analysis and Forecast 2022 to 2032
- 14. East Asia Market 2017 to 2021 Analysis and Forecast 2022 to 2032
- 15. South Asia & Oceania Market 2017 to 2021 Analysis and Forecast 2022 to 2032
- 16. Middle East and Africa Market 2017 to 2021 Analysis and Forecast 2022 to 2032
- 17. Key Countries Market Analysis 2017 to 2021 Analysis and Forecast 2022 to 2032
- 18. Market Structure Analysis
- 19. Competition Analysis
- 19.1. Medtronic Inc.
- 19.2. Edwards Lifesciences Corporation
- 19.3. Boston Scientific Corporation
- 19.4. Abbott Laboratories
- 19.5. St. Jude Medical, Inc.
- 19.6. JenaValve Technology
- 19.7. SYMETIS
- 19.8. Braile Biomedica
- 19.9. CryoLife, Inc.
- 19.10. Micro Interventional Devices, Inc.
- 19.11. LivaNova Plc
- 20. Assumptions & Acronyms Used
- 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1. Global Market Value (US$ Million) and Forecast by Region, 2017 to 2021
Table 2. Global Market Value (US$ Million) and Forecast by Region, 2022 to 2032
Table 3. Global Market Value (US$ Million) and Forecast by Replacement Type, 2017 to 2021
Table 4. Global Market Value (US$ Million) and Forecast by Replacement Type, 2022 to 2032
Table 5. Global Market Value (US$ Million) and Forecast by Surgical Approach, 2017 to 2021
Table 6. Global Market Value (US$ Million) and Forecast by Surgical Approach, 2022 to 2032
Table 7. Global Market Value (US$ Million) and Forecast by End-User, 2017 to 2021
Table 8. Global Market Value (US$ Million) and Forecast by End-User, 2022 to 2032
Table 9. North America Market Value (US$ Million) and Forecast by Country, 2017 to 2021
Table 10. North America Market Value (US$ Million) and Forecast by Country, 2022 to 2032
Table 11. North America Market Value (US$ Million) and Forecast by Replacement Type, 2017 to 2021
Table 12. North America Market Value (US$ Million) and Forecast by Replacement Type, 2022 to 2032
Table 13. North America Market Value (US$ Million) and Forecast by Surgical Approach, 2017 to 2021
Table 14. North America Market Value (US$ Million) and Forecast by Surgical Approach, 2022 to 2032
Table 15. North America Market Value (US$ Million) and Forecast by End-User, 2017 to 2021
Table 16. North America Market Value (US$ Million) and Forecast by End-User, 2022 to 2032
Table 17. Latin America Market Value (US$ Million) and Forecast by Country, 2017 to 2021
Table 18. Latin America Market Value (US$ Million) and Forecast by Country, 2022 to 2032
Table 19. Latin America Market Value (US$ Million) and Forecast by Replacement Type, 2017 to 2021
Table 20. Latin America Market Value (US$ Million) and Forecast by Replacement Type, 2022 to 2032
Table 21. Latin America Market Value (US$ Million) and Forecast by Surgical Approach, 2017 to 2021
Table 22. Latin America Market Value (US$ Million) and Forecast by Surgical Approach, 2022 to 2032
Table 23. Latin America Market Value (US$ Million) and Forecast by End-User, 2017 to 2021
Table 24. Latin America Market Value (US$ Million) and Forecast by End-User, 2022 to 2032
Table 25. Europe Market Value (US$ Million) and Forecast by Country, 2017 to 2021
Table 26. Europe Market Value (US$ Million) and Forecast by Country, 2022 to 2032
Table 27. Europe Market Value (US$ Million) and Forecast by Replacement Type, 2017 to 2021
Table 28. Europe Market Value (US$ Million) and Forecast by Replacement Type, 2022 to 2032
Table 29. Europe Market Value (US$ Million) and Forecast by Surgical Approach, 2017 to 2021
Table 30. Europe Market Value (US$ Million) and Forecast by Surgical Approach, 2022 to 2032
Table 31. Europe Market Value (US$ Million) and Forecast by End-User, 2017 to 2021
Table 32. Europe Market Value (US$ Million) and Forecast by End-User, 2022 to 2032
Table 33. East Asia Market Value (US$ Million) and Forecast by Country, 2017 to 2021
Table 34. East Asia Market Value (US$ Million) and Forecast by Country, 2022 to 2032
Table 35. East Asia Market Value (US$ Million) and Forecast by Replacement Type, 2017 to 2021
Table 36. East Asia Market Value (US$ Million) and Forecast by Replacement Type, 2022 to 2032
Table 37. East Asia Market Value (US$ Million) and Forecast by Surgical Approach, 2017 to 2021
Table 38. East Asia Market Value (US$ Million) and Forecast by Surgical Approach, 2022 to 2032
Table 39. East Asia Market Value (US$ Million) and Forecast by End-User, 2017 to 2021
Table 40. East Asia Market Value (US$ Million) and Forecast by End-User, 2022 to 2032
Table 41. South Asia & Oceania Market Value (US$ Million) and Forecast by Country, 2017 to 2021
Table 42. South Asia & Oceania Market Value (US$ Million) and Forecast by Country, 2022 to 2032
Table 43. South Asia & Oceania Market Value (US$ Million) and Forecast by Replacement Type, 2017 to 2021
Table 44. South Asia & Oceania Market Value (US$ Million) and Forecast by Replacement Type, 2022 to 2032
Table 45. South Asia & Oceania Market Value (US$ Million) and Forecast by Surgical Approach, 2017 to 2021
Table 46. South Asia & Oceania Market Value (US$ Million) and Forecast by Surgical Approach, 2022 to 2032
Table 47. South Asia & Oceania Market Value (US$ Million) and Forecast by End-User, 2017 to 2021
Table 48. South Asia & Oceania Market Value (US$ Million) and Forecast by End-User, 2022 to 2032
Table 49. MEA Market Value (US$ Million) and Forecast by Country, 2017 to 2021
Table 50. MEA Market Value (US$ Million) and Forecast by Country, 2022 to 2032
Table 51. MEA Market Value (US$ Million) and Forecast by Replacement Type, 2017 to 2021
Table 52. MEA Market Value (US$ Million) and Forecast by Replacement Type, 2022 to 2032
Table 53. MEA Market Value (US$ Million) and Forecast by Surgical Approach, 2017 to 2021
Table 54. MEA Market Value (US$ Million) and Forecast by Surgical Approach, 2022 to 2032
Table 55. MEA Market Value (US$ Million) and Forecast by End-User, 2017 to 2021
Table 56. MEA Market Value (US$ Million) and Forecast by End-User, 2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1. Global Market Value (US$ Million) Forecast, 2022 to 2032
Figure 2. Global Market Absolute $ Opportunity (US$ Million), 2022 to 2032
Figure 3. Global Market Value (US$ Million) by Region, 2022 & 2032
Figure 4. Global Market Y-o-Y Growth Rate by Region, 2022 to 2032
Figure 5. Global Market Value (US$ Million) by Replacement Type, 2022 & 2032
Figure 6. Global Market Y-o-Y Growth Rate by Replacement Type, 2022 to 2032
Figure 7. Global Market Value (US$ Million) by Surgical Approach, 2022 & 2032
Figure 8. Global Market Y-o-Y Growth Rate by Surgical Approach, 2022 to 2032
Figure 9. Global Market Value (US$ Million) by End-User, 2022 & 2032
Figure 10. Global Market Y-o-Y Growth Rate by End-User, 2022 to 2032
Figure 11. North America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 12. North America Market Absolute $ Opportunity (US$ Million), 2022 to 2032
Figure 13. North America Market Value (US$ Million) by Country, 2022 & 2032
Figure 14. North America Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 15. North America Market Value (US$ Million) by Replacement Type, 2022 & 2032
Figure 16. North America Market Y-o-Y Growth Rate by Replacement Type, 2022 to 2032
Figure 17. North America Market Value (US$ Million) by Surgical Approach, 2022 & 2032
Figure 18. North America Market Y-o-Y Growth Rate by Surgical Approach, 2022 to 2032
Figure 19. North America Market Value (US$ Million) by End-User, 2022 & 2032
Figure 20. North America Market Y-o-Y Growth Rate by End-User, 2022 to 2032
Figure 21. North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 22. North America Market Attractiveness Analysis by Replacement Type, 2022 to 2032
Figure 23. North America Market Attractiveness Analysis by Surgical Approach, 2022 to 2032
Figure 24. North America Market Attractiveness Analysis by End-User, 2022 to 2032
Figure 25. Latin America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 26. Latin America Market Absolute $ Opportunity (US$ Million), 2022 to 2032
Figure 27. Latin America Market Value (US$ Million) by Country, 2022 & 2032
Figure 28. Latin America Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 29. Latin America Market Value (US$ Million) by Replacement Type, 2022 & 2032
Figure 30. Latin America Market Y-o-Y Growth Rate by Replacement Type, 2022 to 2032
Figure 31. Latin America Market Value (US$ Million) by Surgical Approach, 2022 & 2032
Figure 32. Latin America Market Y-o-Y Growth Rate by Surgical Approach, 2022 to 2032
Figure 33. Latin America Market Value (US$ Million) by End-User, 2022 & 2032
Figure 34. Latin America Market Y-o-Y Growth Rate by End-User, 2022 to 2032
Figure 35. Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 36. Latin America Market Attractiveness Analysis by Replacement Type, 2022 to 2032
Figure 37. Latin America Market Attractiveness Analysis by Surgical Approach, 2022 to 2032
Figure 38. Latin America Market Attractiveness Analysis by End-User, 2022 to 2032
Figure 39. Europe Market Value (US$ Million) Forecast, 2022 to 2032
Figure 40. Europe Market Absolute $ Opportunity (US$ Million), 2022 to 2032
Figure 41. Europe Market Value (US$ Million) by Country, 2022 & 2032
Figure 42. Europe Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 43. Europe Market Value (US$ Million) by Replacement Type, 2022 & 2032
Figure 44. Europe Market Y-o-Y Growth Rate by Replacement Type, 2022 to 2032
Figure 45. Europe Market Value (US$ Million) by Surgical Approach, 2022 & 2032
Figure 46. Europe Market Y-o-Y Growth Rate by Surgical Approach, 2022 to 2032
Figure 47. Europe Market Value (US$ Million) by End-User, 2022 & 2032
Figure 48. Europe Market Y-o-Y Growth Rate by End-User, 2022 to 2032
Figure 49. Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 50. Europe Market Attractiveness Analysis by Replacement Type, 2022 to 2032
Figure 51. Europe Market Attractiveness Analysis by Surgical Approach, 2022 to 2032
Figure 52. Europe Market Attractiveness Analysis by End-User, 2022 to 2032
Figure 53. East Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 54. East Asia Market Absolute $ Opportunity (US$ Million), 2022 to 2032
Figure 55. East Asia Market Value (US$ Million) by Country, 2022 & 2032
Figure 56. East Asia Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 57. East Asia Market Value (US$ Million) by Replacement Type, 2022 & 2032
Figure 58. East Asia Market Y-o-Y Growth Rate by Replacement Type, 2022 to 2032
Figure 59. East Asia Market Value (US$ Million) by Surgical Approach, 2022 & 2032
Figure 60. East Asia Market Y-o-Y Growth Rate by Surgical Approach, 2022 to 2032
Figure 61. East Asia Market Value (US$ Million) by End-User, 2022 & 2032
Figure 62. East Asia Market Y-o-Y Growth Rate by End-User, 2022 to 2032
Figure 63. East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 64. East Asia Market Attractiveness Analysis by Replacement Type, 2022 to 2032
Figure 65. East Asia Market Attractiveness Analysis by Surgical Approach, 2022 to 2032
Figure 66. East Asia Market Attractiveness Analysis by End-User, 2022 to 2032
Figure 67. South Asia & Oceania Market Value (US$ Million) Forecast, 2022 to 2032
Figure 68. South Asia & Oceania Market Absolute $ Opportunity (US$ Million), 2022 to 2032
Figure 69. South Asia & Oceania Market Value (US$ Million) by Country, 2022 & 2032
Figure 70. South Asia & Oceania Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 71. South Asia & Oceania Market Value (US$ Million) by Replacement Type, 2022 & 2032
Figure 72. South Asia & Oceania Market Y-o-Y Growth Rate by Replacement Type, 2022 to 2032
Figure 73. South Asia & Oceania Market Value (US$ Million) by Surgical Approach, 2022 & 2032
Figure 74. South Asia & Oceania Market Y-o-Y Growth Rate by Surgical Approach, 2022 to 2032
Figure 75. South Asia & Oceania Market Value (US$ Million) by End-User, 2022 & 2032
Figure 76. South Asia & Oceania Market Y-o-Y Growth Rate by End-User, 2022 to 2032
Figure 77. South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 78. South Asia & Oceania Market Attractiveness Analysis by Replacement Type, 2022 to 2032
Figure 79. South Asia & Oceania Market Attractiveness Analysis by Surgical Approach, 2022 to 2032
Figure 80. South Asia & Oceania Market Attractiveness Analysis by End-User, 2022 to 2032
Figure 81. MEA Market Value (US$ Million) Forecast, 2022 to 2032
Figure 82. MEA Market Absolute $ Opportunity (US$ Million), 2022 to 2032
Figure 83. MEA Market Value (US$ Million) by Country, 2022 & 2032
Figure 84. MEA Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 85. MEA Market Value (US$ Million) by Replacement Type, 2022 & 2032
Figure 86. MEA Market Y-o-Y Growth Rate by Replacement Type, 2022 to 2032
Figure 87. MEA Market Value (US$ Million) by Surgical Approach, 2022 & 2032
Figure 88. MEA Market Y-o-Y Growth Rate by Surgical Approach, 2022 to 2032
Figure 89. MEA Market Value (US$ Million) by End-User, 2022 & 2032
Figure 90. MEA Market Y-o-Y Growth Rate by End-User, 2022 to 2032
Figure 91. MEA Market Attractiveness Analysis by Country, 2022 to 2032
Figure 92. MEA Market Attractiveness Analysis by Replacement Type, 2022 to 2032
Figure 93. MEA Market Attractiveness Analysis by Surgical Approach, 2022 to 2032
Figure 94. MEA Market Attractiveness Analysis by End-User, 2022 to 2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current valuation of the global transcatheter valve replacement market?
The global transcatheter valve replacement market is estimated to be worth over US$ 3.6 billion in 2022.
How is the market expected to perform over the forecasted period?
The global market for transcatheter valve replacement is predicted to surpass US$ 12.8 Billion by 2032-end.
At what CAGR did demand for transcatheter valve replacement increase over the past years?
Over the 2017-2021 period, the global transcatheter valve replacement market expanded at 10% CAGR.
Who are the prominent players in the global transcatheter valve replacement market?
Some of the prominent players in the transcatheter valve replacement market are Edwards Lifesciences Corporation, Abbott Laboratories, Medtronic Inc., and Boston Scientific Corporation.
Which regional transcatheter valve replacement market leads the way?
North America leads the global transcatheter valve replacement market accounting for 27.2% market share in 2022.
Which transcatheter valve replacement type accounts for the highest market share?
Transcatheter aortic valve replacement (TAVR) accounts for 78.6% share of the global market.
Transcatheter Valve Replacement Market